Schroder Investment Management Group trimmed its holdings in Abbott Laboratories (NYSE:ABT – Free Report) by 9.2% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 956,134 shares of the healthcare product maker’s stock after selling 97,201 shares during the […]
Homestead Advisers Corp reduced its holdings in Abbott Laboratories (NYSE:ABT – Free Report) by 7.8% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 1,015,246 shares of the healthcare product maker’s stock after selling 85,900 shares during the period. Abbott Laboratories accounts for about 2.9% […]
Vinva Investment Management Ltd raised its stake in Abbott Laboratories (NYSE:ABT – Free Report) by 17.5% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 60,449 shares of the healthcare product maker’s stock after purchasing an additional 9,017 shares during the period. Vinva Investment […]
Vinva Investment Management Ltd lifted its stake in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 17.5% during the fourth quarter, Holdings Channel.com reports. The firm owned 60,449 shares of the healthcare product maker’s stock after acquiring an additional 9,017 shares during the period. Vinva Investment Management Ltd’s holdings in Abbott Laboratories were worth […]
Platform Technology Partners boosted its holdings in Abbott Laboratories (NYSE:ABT – Free Report) by 1.3% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 12,732 shares of the healthcare product maker’s stock after purchasing an additional 161 shares during […]